Have a feature idea you'd love to see implemented?
Let us know!

- Stocks
- Healthcare
- NASDAQ: ONVO

Price (delayed)

$0.4579

Market cap

$7.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.38

Enterprise value

$1.99M

Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's

The EPS has increased by 33% year-on-year and by 14% since the previous quarter

ONVO's debt is down by 25% year-on-year and by 8% since the previous quarter

ONVO's quick ratio has soared by 90% from the previous quarter but it is down by 50% YoY

The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year

ONVO's gross profit has dropped by 84% year-on-year and by 35% since the previous quarter

The revenue has plunged by 84% YoY and by 33% from the previous quarter

What are the main financial stats of ONVO

Market
Valuations
Earnings

Shares outstanding

15.36M

Market cap

$7.04M

Enterprise value

$1.99M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.99

Price to sales (P/S)

91.98

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.26

Revenue

$73,000

EBIT

-$13.99M

EBITDA

-$13.7M

Free cash flow

-$12.35M

Per share
Balance sheet
Liquidity

EPS

-$1.38

Free cash flow per share

-$0.84

Book value per share

$0.46

Revenue per share

$0

TBVPS

$0.65

Total assets

$9.47M

Total liabilities

$2.81M

Debt

$1.29M

Equity

$6.66M

Working capital

$5.25M

Debt to equity

0.19

Current ratio

3.58

Quick ratio

3.14

Net debt/EBITDA

0.37

Margins
Efficiency
Dividend

EBITDA margin

-18,769.9%

Gross margin

97.3%

Net margin

-19,160.3%

Operating margin

-19,557.5%

Return on assets

-156%

Return on equity

-224.7%

Return on invested capital

-470.9%

Return on capital employed

-188%

Return on sales

-19,157.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Organovo Holdings stock price performed over time

Intraday

1.53%

1 week

-3.6%

1 month

-16.44%

1 year

-62.16%

YTD

-58.75%

QTD

-10.04%

How have Organovo Holdings's revenue and profit performed over time

Revenue

$73,000

Gross profit

$71,000

Operating income

-$14.28M

Net income

-$13.99M

Gross margin

97.3%

Net margin

-19,160.3%

ONVO's gross profit has dropped by 84% year-on-year and by 35% since the previous quarter

The revenue has plunged by 84% YoY and by 33% from the previous quarter

ONVO's net margin is down by 42% since the previous quarter

The operating margin has declined by 41% since the previous quarter

What is Organovo Holdings's growth rate over time

What is Organovo Holdings stock price valuation

P/E

N/A

P/B

0.99

P/S

91.98

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.26

The EPS has increased by 33% year-on-year and by 14% since the previous quarter

The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year

The stock's price to book (P/B) is 46% less than its last 4 quarters average of 1.8 and 43% less than its 5-year quarterly average of 1.7

The revenue has plunged by 84% YoY and by 33% from the previous quarter

The P/S is 17% above the last 4 quarters average of 77.7

How efficient is Organovo Holdings business performance

The ROE has plunged by 131% YoY and by 15% from the previous quarter

ONVO's return on assets has dropped by 90% year-on-year and by 9% since the previous quarter

ONVO's return on invested capital has dropped by 77% year-on-year and by 7% since the previous quarter

The ROS has declined by 42% since the previous quarter

What is ONVO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ONVO.

How did Organovo Holdings financials performed over time

ONVO's quick ratio has soared by 90% from the previous quarter but it is down by 50% YoY

ONVO's current ratio has soared by 69% QoQ but it is down by 46% YoY

ONVO's debt is 81% smaller than its equity

The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year

The debt to equity has plunged by 51% from the previous quarter but it has grown by 36% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.